Ultra- sustained-release multi-particulate dosage form of Doxycycline as a platform of repurposing therapeutics in the fight against COVID 19: in-vitro and in-silico study

Tocilizumab and Remdesivir Versus Remdesivir Alone in Treatment of Hospitalized Patients with Severe COVID-19 Pneumonia

Suggested Study as a Treatment Protocol for Coronavirus

miRNA-223-3p, miRNA- 2909 and Cytokines Expression in COVID-19 Patients Treated with Ivermectin

Proposed therapies and vaccine developing for COVID-19 (SARS CoV-2)

Clinical Outcomes of Implementing Two Management Protocols for Acute Respiratory Distress Patients with COVID-19: A Randomized Controlled Trial

Impact of N-Acetylcysteine on Modulating Inflammation in Patients Hospitalized with Moderate COVID-19 Infections: A Prospective Randomized Trial

An overview of SARS-COV-2: Virology, Epidemiology, Pathogenesis and Treatment

Could Targeting miRNA-142-5p Be a Therapeutic Strategy Against COVID-19 Through Activation of The Anti-Inflammatory Nrf2/Keap1 Pathway?

The clinical outcome of Tocilizumab in the treatment of elderly patients with severe COVID-19 pneumonia